Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.22B 1.06B 999M 905M 1.7B 117B 1.71B 11.93B 4.59B 59.35B 4.58B 4.48B 189B P/E 2026 *
24.5x
P/E 2027 * 12.6x
Enterprise Value 2.71B 2.35B 2.22B 2.01B 3.77B 260B 3.8B 26.48B 10.19B 132B 10.18B 9.95B 420B EV / Sales 2026 *
1.62x
EV / Sales 2027 * 1.45x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day-0.13%
1 week-3.51%
Current month-7.27%
1 month-14.45%
3 months-10.14%
6 months+69.81%
Current year+26.33%
1 week 15.2
Extreme 15.2
16.22
1 month 15.2
Extreme 15.2
18.37
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
74.98
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Tax

Head of Human Resources

-1,455 0.0019%
03/07/26 Tax

Chief Financial Officer

-5,226 0.0067%
01/07/26 Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-3.51%+4.11%-60.41% 1.22B
-1.03%-3.31%-22.31%+0.29% 177B
-0.05%+1.47%+0.34%+14.65% 120B
-0.90%-0.43%+10.94%+81.33% 61.69B
+1.65%+3.81%+0.10%-29.51% 50.64B
+0.27%-3.53%+3.35%+39.11% 48.16B
+2.09%+2.27%+14.38%-10.28% 32.62B
-1.47%-7.44% - - 28.17B
+2.76%+8.07%+41.73%-7.40% 25.69B
+0.07%-1.06%-10.97%+3.77% 21.33B
Average +0.45%-1.44%+4.63%+3.51% 56.6B
Weighted average by Cap. +0.31%-1.25%-3.24%+12.45%

Financials

2026 *2027 *
Net sales 1.67B 1.45B 1.37B 1.24B 2.33B 161B 2.35B 16.37B 6.3B 81.44B 6.29B 6.15B 260B 1.73B 1.5B 1.42B 1.28B 2.4B 166B 2.42B 16.89B 6.5B 84.03B 6.49B 6.35B 268B
Net income 42.03M 36.41M 34.43M 31.17M 58.5M 4.03B 58.94M 411M 158M 2.04B 158M 154M 6.52B 78.69M 68.16M 64.46M 58.35M 110M 7.55B 110M 769M 296M 3.83B 296M 289M 12.21B
Net Debt 1.49B 1.29B 1.22B 1.1B 2.07B 143B 2.09B 14.56B 5.6B 72.44B 5.59B 5.47B 231B 1.28B 1.11B 1.05B 953M 1.79B 123B 1.8B 12.56B 4.83B 62.5B 4.83B 4.72B 199B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
15/09/26 $15.69 -0.13% 1,077,647
14/09/26 $15.71 +1.35% 1,141,852
11/09/26 $15.50 -0.26% 792,028
10/09/26 $15.54 -4.37% 1,361,972
09/09/26 $16.25 -0.06% 578,400
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
15.69USD
Average target price
19.56USD
Spread / Average Target
+24.64%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!